|
|
HELLP综合征的诊治进展 |
李亦凡 综述, 冯碧波 审校 |
100176 北京,首都医科大学第四临床医学院(李亦凡);首都医科大学附属北京同仁医院妇产科(冯碧波) |
|
|
摘要 HELLP综合征是一种妊娠期子痫前期的严重并发症。尽管国内外对于HELLP综合征的认识在不断加深,但子痫前期并发HELLP综合征对母婴危害极大,是孕产妇和围产期发病率和死亡率的重要原因之一。约20%的患者无高血压病史,且病情与妊娠期高血压疾病严重程度并不一致,常因高血压的临床表现不明显而漏诊,因此,临床对HELLP综合征正确及时地处理很重要。近年来,循证医学证据对HELLP综合征的处理和远期预后提出了新的观点。本文对HELLP综合征的诊治进展做一综述,以期提高对这一疾病的认识水平。
|
|
关键词 :
HELLP综合征,
子痫前期,
溶血,
肝酶升高,
血小板减少
|
收稿日期: 2019-08-26
|
通讯作者:
冯碧波(fb55555@qq.com)
|
1 Morton A.Imitators of preeclampsia:A review.Pregnancy Hypertens,2016,6:1-9.
2 周婧雅,张萌,李舒,等.子痫前期国际疾病分类规则的修订进展研究.中国病案,2018,19:24-26.
3 Sibai BM,Ramadan MK,Usta I,et al.Maternal morbidity and mortality in 442 pregnancies with hemolysis,elevated liver enzymes,and low platelets (HELLP syndrome).Am J Obstet Gynecol,1993,169:1000-1006.
4 Le Thi Thuong D,Tieulié N,Costedoat N,et al.The HELLP syndrome in the antiphospholipid syndrome:retrospective study of 16 cases in 15 women.Ann Rheum Dis,2005,64:273.
5 李永梅,汪云.HELLP综合征发病机理的相关概述.中国妇幼保健,2019,34:2900-2903.
6 Mihu D,Costin N,Mihu CM,et al.HELLP syndrome - a multisystemic disorder.J Gastrointestin Liver Dis,2007,16:419-424.
7 杨孜,张为远,妊娠期高血压疾病诊治指南(2015).中华产科急救电子杂志,2015,4:206-213.
8 Rimaitis K,Grauslyte L,Zavackiene A,et al.Diagnosis of HELLP Syndrome:A 10-Year Survey in a Perinatology Centre.Int J Environ Res Public Health,2019,16:109.
9 ACOG.ACOG Practice Bulletin No.202:Gestational Hypertension and Preeclampsia.Obstet Gynecol,2019,133:e1-e25.
10 Haram K,Mortensen JH,Mastrolia SA,et al.Disseminated intravascular coagulation in the HELLP syndrome:how much do we reallyknow? J Matern Fetal Neonatal Med,2017,30:779-788.
11 Schnabel A,Blois SM,Meint P,et al.Elevated systemic galectin-1 levels characterize HELLP syndrome.J Reprod Immunol,2016,114:38-43.
12 Abildgaard U,Heimdal K.Pathogenesis of the syndrome of hemolysis,elevated liver enzymes,and low platelet count (HELLP):a review.Eur J Obstet Gynecol Reprod Biol,2013,166:117-123.
13 Munoz-Hernandez R,Medrano-Campillo P,Miranda ML,et al.Total and Fetal Circulating Cell-Free DNA,Angiogenic,and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.Am J Hypertens,2017,30:673-682.
14 Woudstra DM,Chandra S,Hofmeyr GJ,et al.Corticosteroids for HELLP (hemolysis,elevated liver enzymes,low platelets) syndrome in pregnancy.Cochrane Database Syst Rev,2010:D8148.
15 Mecacci F,Carignani L,Cioni R,et al.Time course of recovery and complications of HELLP syndrome with two different treatments:heparin or dexamethasone.Thromb Res,2001,102:99-105.
16 Yang L,Ren C,Mao M,et al.Prognostic Factors of the Efficacy of High-dose Corticosteroid Therapy in Hemolysis,Elevated Liver Enzymes,and Low Platelet Count Syndrome During Pregnancy:A Meta-analysis.Medicine (Baltimore),2016,95:e3203.
17 Cavaignac-Vitalis M,Vidal F,Simon-Toulza C,et al.Conservative versus active management in HELLP syndrome:results from a cohort study.J Matern Fetal Neonatal Med,2017,32:1-7.
18 Churchill D,Duley L,Thornton JG,et al.Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks′ gestation.Cochrane Database Syst Rev,2018,10:D3106.
19 康苏娅,周丽屏,汪云,等.HELLP综合征期待治疗时间的探讨.国际妇产科学杂志,2018,45:46-50.
20 李霞,孔为民,姜艳.妊娠期血小板减少疾病研究进展.中国计划生育和妇产科,2017,9:19-23.
21 Sibai BM.Diagnosis,controversies,and management of the syndrome of hemolysis,elevated liver enzymes,and low platelet count.Obstet Gynecol,2004,103:981-991.
22 郑瑞丹.HELLP综合征的临床诊治.中国临床医生杂志,2015,43:6-10.
23 del-Rio-Vellosillo M,Garcia-Medina JJ.Anesthetic considerations in HELLP syndrome.Acta Anaesthesiol Scand,2016,60:144-157.
24 Travnikova M,Gumulec J,Koristek Z,et al.[HELLP syndrome requiring therapeutic plasma exchange due to progression to multiple organ dysfunction syndrome with predominant encephalopathy,respiratory and renal insufficiency].Ceska Gynekol,2017,82:202-205.
25 Erkurt MA,Berber I,Berktas HB,et al.A life-saving therapy in Class I HELLP syndrome:Therapeutic plasma exchange.Transfus Apher Sci,2015,52:194-198.
26 Varotti G,Andorno E,Valente U.Liver transplantation for spontaneous hepatic rupture associated with HELLP syndrome.Int J Gynecol Obstet,2010,111:84-85. |
[1] |
刘兆董, 赵扬玉, 魏瑗, 杨静. 子痫前期双胎孕妇血小板参数及凝血功能指标变化的临床分析[J]. 中国生育健康杂志, 2020, 31(3): 210-214. |
[2] |
卢珊, 高雨菲, 张龑, 淮瑞敏, 赵扬玉, 魏瑗. HELLP综合征实验室特点分析[J]. 中国生育健康杂志, 2020, 31(2): 127-131. |
[3] |
杨舒奇, 黄明莉, 黄凌佳, 孙欣. 血管内皮生长因子家族在妇产科若干疾病中的研究进展[J]. 中国生育健康杂志, 2020, 31(2): 184-186. |
[4] |
杨桦, 王小菊. HELLP综合征合并肝破裂1例分析及文献复习[J]. 中国生育健康杂志, 2019, 30(6): 576-579. |
[5] |
刘冬玲, 许琦, 王雁, 魏俊, 刘国莉. 26周前发病的重度子痫前期患者的母儿结局及再孕管理[J]. 中国生育健康杂志, 2019, 30(5): 411-414. |
[6] |
颜露春, 朱广源, 李小林, 叶蔚. 子痫前期孕妇外周血sFlt-1、PIGF、PP-13、sEng的表达及其与子宫动脉血流的相关性研究[J]. 中国生育健康杂志, 2019, 30(3): 237-240. |
[7] |
郑林媚,施蕾,周忠义,陈小菊,王莉,唐荣,卢志诚. 胆碱能抗炎通路在子痫前期患者母胎界面的表达及意义[J]. 中国生育健康杂志, 2019, 30(1): 15-20. |
[8] |
冯向春,毕晓娜,孙印兰,单若冰. 临床路径在新生儿ABO溶血病中的管理效果[J]. 中国生育健康杂志, 2018, 29(5): 460-461. |
[9] |
刘方琮,张晗,蔡丽瑛. 胰岛素样生长因子结合蛋白-1与子痫前期及胎儿生长受限的相关研究进展[J]. 中国生育健康杂志, 2018, 29(5): 485-486. |
[10] |
马媛媛, 魏瑗, 赵扬玉. HCG注射日血清孕酮水平与取卵周期移植单胎妊娠产科结局的相关性[J]. 中国生育健康杂志, 2018, 29(1): 55-57. |
[11] |
郝彦兰, 毛东伟, 郭瑞军, 郝秋亚. IL-8在子痫前期患者血清及胎盘中的表达及意义[J]. 中国生育健康杂志, 2018, 29(1): 58-60. |
[12] |
刘英,罗丽琼,张桂丽,王香华,鲁翠萍. 再发性子痫前期的临床病理特征及远期母子预后的单中心临床研究[J]. 中国生育健康杂志, 2017, 28(5): 470-471. |
[13] |
王贝. 孕前体重指数、孕期体重增加与子痫前期在基层医院的妊娠结局关系[J]. 中国生育健康杂志, 2017, 28(5): 481-483. |
[14] |
马俊如. 妊娠合并血小板减少症患者不同分娩方式对产后出血和新生儿窒息的影响[J]. 中国生育健康杂志, 2017, 28(4): 367-369. |
[15] |
李翠莲,杨跃煌,刘红林,刘玲. 严重高胆红素血症新生儿换血治疗后血小板减少症的危险因素[J]. 中国生育健康杂志, 2017, 28(3): 233-236. |
|
|
|
|